Neurodyn’s goal is to be a leader in discovering and developing bioactive compounds into treatments for neurological diseases.
To ensure success, Neurodyn has embraced a ‘Poly-pharmacological’ methodology to drug development which may explain the compelling effectiveness of the technologies developed to date.
Neurological disease research leads the way
Technology development is greatly facilitated by the company’s full suite of services and expertise. Through CNS|CRO proprietary environmentally based animal models are offered that more accurately reflect the slow progression of neurological disease in humans than current models. Through NeuroQuest Inc., full synthetic and medicinal chemistry capacity, as well as in vitro screening, for the molecular modification and improvement of bioactives is available.
8 total views, 1 today